Palatin Technologies Inc (PTN) stock

PTNNasdaqPharmaceutical PreparationsFiscal year ends June 30

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 28, 2026Score 6/30

$6.23−0.34 (-5.18%)

Close on Nov 13, 2026Market cap $11.10MP/E –Yield –

Palatin Technologies EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Palatin Technologies's EV/EBITDA was 89.8× on Jul 31, 2020, against 380.4× a year earlier. Over the last 3 years it ranged from 64.3× to 447.2×, with a median of 94.0×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2020	Jul 31, 2020	89.8×	−29.0
2019	Dec 31, 2019	118.8×	−272.8
2018	Dec 31, 2018	391.6×	+312.6
2017	Dec 29, 2017	79.0×	–

Where these numbers come from

Parsed from the XBRL in Palatin Technologies's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-50 reverse split on Aug 12, 2025
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is PTN.

Compare: PTN vs BIOA · PTN vs RANI · PTN vs ALMS · PTN vs EVMN · PTN vs PRAX

Operating margin-98.2% · median -1401.8%

Net margin-94.9% · median -1253.6%

Company	Revenue	Growth
PTN	$8.83M	–
BIOA	$8.60M	+45.3%
ALMS	$7.24M	–
RANI	$6.58M	+448.7%
EVMN	$0	-100.0%
PRAX	–	–

Company

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
Fiscal year ends: June 30
Employees: 25
Held by institutions: 38.5%
Auditor: KPMG LLP
SEC CIK: 911216

Advertisement
300 × 250

See a number that looks wrong?

Palatin Technologies EV/EBITDA

EV/EBITDA at the end of each year

More Palatin Technologies figures